---
figid: PMC8551152__41389_2021_361_Fig6_HTML
figtitle: Schematic diagram
organisms:
- NA
pmcid: PMC8551152
filename: 41389_2021_361_Fig6_HTML.jpg
figlink: /pmc/articles/PMC8551152/figure/Fig6/
number: F6
caption: IDH1 mutation suppressed the TGF-β signaling pathway and E2F4 interacted
  with Smad3 to inhibit expression of mesenchymal markers in the proneural subtype
  of GBM. However, palmitoylation of Smad3 mediated by palmitoyltransferase ZDHCH19
  promoted activation of the TGF-β signaling pathway and its interaction with EP300
  to promote expression of mesenchymal markers in the mesenchymal subtype of GBM.
  GBM glioblastoma, IDH1 isocitrate dehydrogenase 1.
papertitle: Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation.
reftext: Xiaoqing Fan, et al. Oncogenesis. 2021 Oct;10(10):72.
year: '2021'
doi: 10.1038/s41389-021-00361-8
journal_title: Oncogenesis
journal_nlm_ta: Oncogenesis
publisher_name: Nature Publishing Group UK
keywords: Cancer stem cells | CNS cancer | Targeted therapies
automl_pathway: 0.9330576
figid_alias: PMC8551152__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8551152__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8551152__41389_2021_361_Fig6_HTML.html
  '@type': Dataset
  description: IDH1 mutation suppressed the TGF-β signaling pathway and E2F4 interacted
    with Smad3 to inhibit expression of mesenchymal markers in the proneural subtype
    of GBM. However, palmitoylation of Smad3 mediated by palmitoyltransferase ZDHCH19
    promoted activation of the TGF-β signaling pathway and its interaction with EP300
    to promote expression of mesenchymal markers in the mesenchymal subtype of GBM.
    GBM glioblastoma, IDH1 isocitrate dehydrogenase 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IDH1
  - MMUT
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - TGFB1
  - E2F4
  - TGFB2
  - TGFB3
  - PAM
  - LRIT1
  - SHCBP1
  - SMAD3
  - EP300
  - CHI3L1
  - CD44
  - TIMP1
  - BCL3
  - ZDHHC19
---
